+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Demecolcine (CAS 477-30-5) Global Market Research Report 2024 - Product Thumbnail Image

Demecolcine (CAS 477-30-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Decitabine (CAS 2353-33-5) Global Market Research Report 2024 - Product Thumbnail Image

Decitabine (CAS 2353-33-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
From
Dacarbazine (CAS 4342-03-4) Global Market Research Report 2024 - Product Thumbnail Image

Dacarbazine (CAS 4342-03-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Cyclopentolate (CAS 512-15-2) Global Market Research Report 2024 - Product Thumbnail Image

Cyclopentolate (CAS 512-15-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Celiprolol (CAS 56980-93-9) Global Market Research Report 2024 - Product Thumbnail Image

Celiprolol (CAS 56980-93-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Cediranib (CAS 288383-20-0) Global Market Research Report 2024 - Product Thumbnail Image

Cediranib (CAS 288383-20-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Cladribine (CAS 4291-63-8) Global Market Research Report 2024 - Product Thumbnail Image

Cladribine (CAS 4291-63-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Cilengitide (CAS 188968-51-6) Global Market Research Report 2024 - Product Thumbnail Image

Cilengitide (CAS 188968-51-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Crizotinib (CAS 877399-52-5) Global Market Research Report 2024 - Product Thumbnail Image

Crizotinib (CAS 877399-52-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bosutinib (CAS 380843-75-4) Global Market Research Report 2024 - Product Thumbnail Image

Bosutinib (CAS 380843-75-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bortezomib (CAS 179324-69-7) Global Market Research Report 2024 - Product Thumbnail Image

Bortezomib (CAS 179324-69-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bicalutamide (CAS 90357-06-5) Global Market Research Report 2024 - Product Thumbnail Image

Bicalutamide (CAS 90357-06-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Cepharanthine (CAS 481-49-2) Global Market Research Report 2024 - Product Thumbnail Image

Cepharanthine (CAS 481-49-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more